Develco Pharma Overview
- Year Founded
-
2006
- Status
-
Private
- Employees
-
180
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
4
- Investments
-
1
Develco Pharma General Information
Description
Provider of medical research and development services intended to offer advanced pharmaceutical ingredients. The company's services include sourcing, project management, analytics, clinical development, and registration, which combine with the technology for the manufacturing of medical products and provide contract manufacturing services, enabling healthcare professionals to offer advanced pharmaceutical products to their patients and ensure a quick recovery.
Contact Information
Website
www.develco.chCorporate Office
- Hohenrainstrasse 12 D
- 4133 Pratteln
- Switzerland
Corporate Office
- Hohenrainstrasse 12 D
- 4133 Pratteln
- Switzerland
Develco Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Develco Pharma Patents
Develco Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3641742-A2 | Hydroxynorketamine for the use in the treatment of depression | Pending | 23-Jun-2017 | ||
| US-20210059944-A1 | Novel dosage form | Pending | 09-Mar-2017 | ||
| EP-3372225-A1 | Novel dosage form | Pending | 09-Mar-2017 | ||
| CA-3053696-A1 | Novel dosage form | Pending | 09-Mar-2017 | ||
| AU-2018232854-A1 | Novel dosage form | Active | 09-Mar-2017 | A61K9/167 |
Develco Pharma Executive Team (9)
| Name | Title | Board Seat |
|---|---|---|
| Martin Renner Ph.D | Chief Executive Officer | |
| Markus Gerstner | Chief Financial Officer | |
| Marc Fischer | Chief Operating Officer | |
| Mathias Scheer | Managing Director, Germany | |
| Helene Rey | Head of Research and Development and Creative Director |
Develco Pharma Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| SHS Capital | Board Member | ||
| Ketabon | Board Member | ||
| Self | Chairman |
Develco Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Develco Pharma Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Develco Pharma Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Ketabon | 01-Apr-2021 | BPO/Outsource Services |
Develco Pharma FAQs
-
When was Develco Pharma founded?
Develco Pharma was founded in 2006.
-
Who is the founder of Develco Pharma?
Mathias Scheer and Dirk Kramer are the founders of Develco Pharma.
-
Who is the CEO of Develco Pharma?
Martin Renner Ph.D is the CEO of Develco Pharma.
-
Where is Develco Pharma headquartered?
Develco Pharma is headquartered in Pratteln, Switzerland.
-
What is the size of Develco Pharma?
Develco Pharma has 180 total employees.
-
What industry is Develco Pharma in?
Develco Pharma’s primary industry is Pharmaceuticals.
-
Is Develco Pharma a private or public company?
Develco Pharma is a Private company.
-
What is Develco Pharma’s current revenue?
The current revenue for Develco Pharma is .
-
Who are Develco Pharma’s investors?
Qualitas Funds has invested in Develco Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
